gemcitabine has been researched along with bms345541 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Contreras, JI; Ezell, EL; Garrison, JC; Kizhake, S; Mallareddy, JR; Napoleon, JV; Natarajan, A; Radhakrishnan, P; Rajesh, C; Rana, S; Sagar, S; Singh, S; Sonawane, YA | 1 |
1 other study(ies) available for gemcitabine and bms345541
Article | Year |
---|---|
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; I-kappa B Kinase; Mice; Molecular Structure; Pancreatic Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Quinoxalines; Structure-Activity Relationship; Urea | 2021 |